GLP-1 SM 20mg Peptides
Engineered for precision, this research-grade GLP-1 SM vial delivers consistent performance when accuracy and reproducibility matter most.
The GLP-1 SM Peptide Lyophilized Vial from Well Elevation is a clean, research-focused preparation designed to meet rigorous laboratory expectations. Presented as a stable lyophilized powder (unflavored, lab style), this single-vial format contains a total of 20mg GLP-1 SM for controlled in vitro protocol development, method calibration, and analytical work.
- Each vial contains 20mg of GLP-1 SM, a research peptide widely used to study GLP-1 receptor signaling dynamics, potency profiling, assay development, and formulation stability under defined laboratory conditions.
This non-edible preparation is produced for consistency across runs and straightforward lab workflows. The lyophilized format supports measured handling, predictable reconstitution behavior, and compatibility with common analytical techniques. Researchers value its reliable appearance, uniform particulate structure, and the way it integrates into controlled studies such as receptor engagement assessments, time-course analyses, and physicochemical evaluations.
Best suited to bench environments that prioritize documentation and traceability, each vial is lot-coded for clear recordkeeping and process control. Laboratories can incorporate this material into validated procedures for quantitative analysis, in vitro exploration, and materials characterization without the distractions of flavors or excipients unnecessary to research goals.
Quality and trust, built into every lot:
- Produced in the USA under stringent quality controls with meticulous handling and chain-of-custody documentation.
- Identity and purity verified by established analytical techniques (HPLC and LC-MS), supporting reproducible results and informed method development.
- Lot tracking, batch documentation, and transparent specifications reinforce consistency and confidence at scale.
Well Elevation is committed to standards that do not compromise: exacting materials, careful presentation, and reliable data support. From sourcing through final inspection, our processes reflect a research-first mindset where purity, consistency, and clarity are non-negotiable.
For laboratory research only. Not for human consumption, medical, or veterinary use. Handle using appropriate laboratory safety practices and according to your institutional SOPs.
- Most orders ship within 24 hours and arrive within 3 to 5 days of leaving our warehouse.
- Shipping is free on orders of $99+ (except Hawaii and Alaska).
- All orders ship in discreet packaging via USPS Ground Advantage mail.
Delivery restrictions vary by state.
This Product Contains
Customer Reviews
There are no reviews yet. Be the first to write a review!
Frequently Asked Questions
What is GLP-1 SM?
GLP-1 SM appears to be a supplier-specific GLP-1-based research product. The 'SM' label is not a standardized pharmacologic name, so a careful description should avoid guessing the exact analog unless the sequence or active ingredient is shown on the specification sheet. It is best framed as a GLP-1-pathway research compound for laboratory use only.
What is GLP-1 SM typically studied for?
GLP-1-based compounds are generally studied for appetite regulation, glucose handling, insulin-related signaling, and body-weight change in metabolic models. For this specific item, the strongest FAQ wording is to explain the GLP-1 research category while also telling users to confirm the exact analog on the lot documents.
What are GLP peptides?
GLP peptides — glucagon-like peptides — are a family of peptides derived from the post-translational processing of the proglucagon precursor. The main members are GLP-1 and GLP-2, both of which are produced primarily by intestinal L-cells. GLP-1 is studied in the context of insulin secretion, glucose metabolism, and appetite signaling, while GLP-2 is investigated for its role in intestinal epithelial biology.
A number of synthetic analogs and research compounds exist in this category, including semaglutide-class and tirzepatide-class sequences, as well as dual- and triple-agonist research peptides. All GLP peptide products from Well Elevation are lyophilized research materials intended solely for in vitro laboratory investigation.
How do GLP analogs differ from native GLP hormones?
Native GLP-1 has a very short half-life in plasma — on the order of a few minutes — because it is rapidly degraded by the enzyme dipeptidyl peptidase-4 (DPP-4). GLP analogs are engineered peptides that modify the native sequence or attach additional groups such as fatty acid chains, in order to resist DPP-4 degradation, extend half-life, and optimize receptor binding.
This extended stability is what makes GLP analogs useful in research as practical tools for studying the GLP-1 and related receptor systems in controlled experiments. The analogs differ from native GLP hormones primarily in their pharmacokinetic profile and, in some cases, their receptor selectivity across the GLP-1, GIP, and glucagon receptor families.
What is the difference between GLP-1, GLP-2, and GLP-3 in research?
GLP-1 and GLP-2 are both produced from the proglucagon precursor. GLP-1 is studied in connection with the GLP-1 receptor, insulin secretion, and appetite signaling, while GLP-2 is studied primarily in connection with the GLP-2 receptor and intestinal epithelial biology. The two peptides share a common precursor but have different receptor targets and research focuses.
GLP-3 is not a classical endogenous peptide in the same way as GLP-1 and GLP-2. The term is sometimes used as a research label for engineered or triple-agonist peptides that combine activity at GLP-1, GIP, and glucagon receptors in a single molecule. In this sense, GLP-3 in research usually refers to a designed multi-target compound rather than a naturally occurring hormone.
